10,000 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Eu Ivd General
×
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
COLLAGEN TYPE III C-TERMINAL PROPEPTIDE
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 50
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 242
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CALCITONIN
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CALCITONIN
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market